These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7471743)

  • 1. Low dose injectable contraceptive norethisterone enanthate 20mg monthly - II. Metabolic side effects.
    Bamji MS; Safaya S; Prema K
    Contraception; 1981 Jan; 23(1):23-36. PubMed ID: 7471743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
    Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
    Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
    Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
    Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
    Joshi JV; Hazari KT; Shah RS; Chadha UC; Chitlange S; Gokral JS; Arolkar SG
    Steroids; 1989 Jun; 53(6):751-61. PubMed ID: 2815152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral contraceptive agents on nutrients: II. Vitamins.
    Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
    Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
    Amatayakul K; Petpoo W; Ratanawananukul N; Tanthayaphinant O; Tovanabutra S; Suriyanon V
    Contraception; 1988 May; 37(5):483-92. PubMed ID: 2970367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on some enzymes and sialic acid during progestational contraceptive therapy.
    Chaudhuri C; Mukherjea M
    Contraception; 1984 Jun; 29(6):573-83. PubMed ID: 6467944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and biochemical changes after low-dose oral contraception.
    Loke DF; Ng CS; Holck S; Hall PE; Ratnam SS
    Contraception; 1992 Sep; 46(3):227-41. PubMed ID: 1451519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.
    Saleh FM
    Contraception; 1977 Oct; 16(4):399-407. PubMed ID: 923250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
    Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some metabolic and hormonal changes in women using long acting injectable contraceptives.
    Abdel-sayed WS; Toppozada HK; Said SA; El-sayed OK
    Alex J Pharm Sci; 1989 Mar; 3(1):29-32. PubMed ID: 12316139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
    Andino N
    Contraception; 1981 Feb; 23(2):141-55. PubMed ID: 6786825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X.
    Howard G; Myatt L; Elder MG
    Br J Obstet Gynaecol; 1977 Aug; 84(8):618-21. PubMed ID: 889752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of sex, age, synthetic oestrogens, progestogens and oral contraceptives on the excretion of urinary tryptophan metabolites.
    Moursi GE; Abdel-Daim MH; Kelada NL; Abdel-Tawab GA; Girgis LH
    Bull World Health Organ; 1970; 43(5):651-61. PubMed ID: 5313362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
    Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
    Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
    Horwitt MK; Harvey CC; Dahm CH
    Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.